

William Blair starts Enovis at Outperform, citing FCF improvement, conservative growth outlook, and Arvis relaunch.
You can purchase shares of Enovis (NYSE:ENOV) through any online brokerage.
Other companies in Enovis’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
Enovis has a consensus price target of $45.21.
The stock price for Enovis (NYSE: ENOV) is $21.08 last updated October 23, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Enovis.
Enovis does not have any upcoming earnings scheduled.
There is no upcoming split for Enovis.
Enovis is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical...